Protein expression refers to the process through which proteins are synthesised in living organisms. In in-vitro conditions, protein expression is the process in which laboratory techniques are used for manufacturing proteins.
Increasing biochemical studies and their application in the production of new materials is boosting the global market for protein expression technology. This technology is also widely used in genetic modification procedures to increase the yield and quality of the proteins derived from living cells. As biotechnology-based drugs gain traction, adoption of protein expression technology is expected to gain momentum in the future.
Protein Expression Technology Market: Drivers and Restraints
Use of protein expression technology in synthesising biotechnology-based medicines and artificial enzymes is a key factor fuelling the growth of the market globally. Development in the field of proteomics is also expected to boost the market during the forecast period 2016-2026. Increasing demand for recombinant DNA products in the healthcare sector and growing demand for industrial proteins will also support the growth of the market during the forecast period.
Continuous technological advancements in the field of genetic engineering for development of personalised medicine, monitoring cellular response, and developing targeted therapies are the other key drivers for the global protein expression technology market. However, stringent laws, approval policies of certain therapeutic proteins, and high cost of the products required in R&D might negatively affect the protein expression technology market. Moreover, the technology for effectively developing membrane proteins that play an important role in being the target site for several therapeutic agents is not much developed. Though several companies are trying to develop techniques for manufacturing advanced cell lines and media, the technological restraint in development of low-cost protein expression technology is major restraint in the market.
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1540
Protein Expression Technology Market: Segmentation
The global protein expression technology market is segmented on the basis of product type and end user.
By Product Type
- Component Cells
- Expression Vectors
- Bacterial Expression
- Insect Expression
- Yeast Expression
- Mammalian Expression
By End User
- R&D Labs
- Pharmaceutical companies
- Biotech Companies
- Academic Institutions
- CRO (Clinical Research Organisations)
Protein Expression Technology Market: Region-wise Outlook
FMI’s report on the protein expression technology market offers market forecast and analysis on North America, Latin America, Western Europe Eastern Europe, Japan, APEJ (Asia Pacific excluding Japan) and MEA (Middle East and Africa).
North America and Western Europe are the leading markets for protein expression technology. High adoption rate of personalised medicines, along with increasing investment in healthcare R&D are driving the growth of the market in these regions.
Protein expression technology market in emerging regions, such as Latin America and APEJ is expected to grow at a promising rate owing to increasing FDI in the healthcare sector. Moreover, growth in the pharmaceutical research outsourcing sector in India and China will also stimulate the protein expression technology market in APEJ region during the forecast period. Emphasis on the agricultural research for development for plant viral-vector based protein expression technology is expected to gain traction in APEJ region due to adoption of genetic engineering for increasing agricultural yield. The protein expression technology market in Latin America and MEA is also expected to witness steady growth during the forecast period, owing to increasing emphasis on boosting the healthcare sector.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1540
Protein Expression Technology Market: Key Market Players
Key participants in the protein expression technology market are Qiagen N.V., Sigma-Aldrich Co. LLC. Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., EMD Millipore Corp., Oxford Expression Technologies Ltd., Promega Corporation, and Takara Bio Inc.